Home ›
Trademark Categories ›
Pharmaceuticals ›
2020 ›
ON ›
ONCXERNA
Trademark search for:
ONCXERNA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2020-09-25 — Application filed
2020-09-29 — Application filed
2020-10-15 — Teas change of owner address received
2020-10-15 — Teas change of correspondence received
2020-10-15 — Applicant/correspondence changes (non-responsive) entered
2020-11-05 — Application filed
2020-12-07 — Assigned to examiner
2020-12-10 — Final disposition recorded
2020-12-10 — Final disposition recorded
2020-12-10 — Final disposition recorded
2021-06-10 — Teas/email correspondence entered
2021-06-10 — Office action issued
2021-06-10 — Correspondence received in law office
2021-06-12 — Approved for pub - principal register
2021-06-30 — Notification of notice of publication e-mailed
2021-07-20 — Published for opposition
2021-07-20 — Official gazette publication confirmation e-mailed
2021-09-14 — Noa e-mailed - sou required from applicant
2022-01-27 — Sou teas extension received
2022-01-27 — Sou extension 1 filed
2022-01-27 — Sou extension 1 granted
2022-01-29 — Notice of approval of extension request e-mailed
2022-09-07 — Sou teas extension received
2022-09-07 — Sou extension 2 filed
2022-09-07 — Sou extension 2 granted
2022-09-09 — Notice of approval of extension request e-mailed
2023-02-22 — Sou teas extension received
2023-02-22 — Sou extension 3 filed
2023-02-22 — Sou extension 3 granted
2023-02-24 — Notice of approval of extension request e-mailed
2023-09-14 — Sou teas extension received
2023-09-14 — Sou extension 4 granted
2023-09-14 — Sou extension 4 filed
2023-09-16 — Notice of approval of extension request e-mailed
2024-04-15 — Application abandoned
2024-04-15 — Application abandoned
2024-04-15 — Final status recorded
Owner Information
ONCXERNA THERAPEUTICS, INC.
ONCXERNA THERAPEUTICS, INC.
Correspondent
Monica Riva Talley STERNE, KESSLER, GOLDSTEIN & FOX P.L.L.C
Filing Details
Filing Date:
Status Date:
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.
